Zhiguo Luo, MD, PhD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Pucotenlimab Combined with MRG002 for HER2-positive Cancer of Unknown Primary (NCT06869174) | Zhiguo Luo, MD, PhD | 2025-03-08 |
Track Zhiguo Luo, MD, PhD automatically
Every clearance here is in the API, with alerts when new ones post.